News
The most recent news and industry headlines are presented in this section. Our dedicated team closely observes the pharmaceutical industry and keeps you informed of the most recent developments around the Europe.
Bluejay Therapeutics Receives Positive Opinion on Orphan Designation from European Medicines Agency for BJT-778 Targeting Chronic Hepatitis D
Thursday, May 30, 2024Bluejay Therapeutics a clinicalstage biopharmaceutical company focused on addressing viral and liver diseases with unmet medical needs has received positive news from the European Medicines Agency
Coriolis Pharma Announces Launch of U.S. Entity, Offering Innovative Services for Monoclonal Antibodies
Thursday, May 30, 2024Coriolis Pharma a prominent player in RD and GMP drug product development analytics and sterile drug manufacturing support has announced the establishment of its US entity This move signifies
Unravel Biosciences Secures FDA Orphan Drug Designation for Vorinostat (RVL-001) in Rett Syndrome Treatment
Wednesday, May 29, 2024Unravel Biosciences Inc has just received Orphan Drug Designation from the United States Food and Drug Administration for vorinostat as a potential treatment for Rett Syndrome
Evotec and CHDI Foundation Extend Strategic Partnership for Huntington’s Disease Drug Discovery
Wednesday, May 29, 2024Evotec SE has recently announced the extension of its collaboration with CHDI Foundation Inc CHDI a nonprofit organization dedicated to advancing therapies for Huntingtons disease aims to significantly
Cartography Enters Strategic Collaboration with Gilead to Develop Oncology Treatments Targeting New and Combined Targets
Wednesday, May 29, 2024Cartography Biosciences Inc has unveiled a new strategic collaboration with Gilead Sciences Inc aimed at developing therapies for patients with triplenegative breast cancer
Menten AI Concludes Successful Research Partnership with Bristol Myers Squibb
Wednesday, May 29, 2024Menten AI Inc a biotech company specializing in peptide macrocycle design and optimization through AI has announced the completion of a collaborative research venture with Bristol Myers Squibb
Helsinn and Angelini Pharma Extend Partnership to Market AULIN® and MESULID® in Bulgaria, Czech Republic, Hungary, Poland, Romania, and Slovak Republic
Tuesday, May 28, 2024Helsinn Group a prominent pharmaceutical company specializing in supportive care oncology and
Tyligand Bioscience Initiates Phase 1/2 Clinical Trial for TSN1611, a Selective Oral KRAS G12D Inhibitor, with First Patient Dosed
Monday, May 27, 2024Tyligand Bioscience a prominent biotechnology company focused on developing cuttingedge cancer therapies has reached a significant milestone with the initiation of the Phase trial of TSN
Sarah Cannon Research Institute Expands into East Tennessee through Partnership with Tennessee Cancer Specialists
Friday, May 24, 2024The Sarah Cannon Research Institute a leader in oncology research and communitybased clinical trials has announced a collaboration with Tennessee Cancer Specialists an independent oncology
Abdera Therapeutics Receives FDA Clearance for ABD-147 IND Application
Friday, May 24, 2024Abdera Therapeutics Inc a biopharmaceutical company specializing in precision radiopharmaceuticals for cancer treatment has received clearance from the US Food and Drug Administration for its Investigational New Drug application regarding ABD This ma...
